Melatonin use and the risk of self‐harm and unintentional injuries in youths with and without psychiatric disorders

Abstract

BackgroundSleep disorders in youth have been associated with increased risks of injury, including suicidal behavior. This study investigated whether melatonin, which is the most common medication for sleep disturbances in youth in Sweden, is associated with a decreased risk of injury.MethodsThis population‐based cohort study included 25,575 youths who initiated melatonin treatment between ages 6 and 18. Poisson regression was used to estimate rate of injuries in the year prior to and following melatonin treatment initiation. A within‐individual design was used to estimate relative risks by comparing injury risk in the last unmedicated month with injury risks in the 12 months after medication initiation. Analyses were stratified by sex, injury type, psychiatric comorbidities and age at melatonin‐treatment initiation.ResultsWhile body injuries, falls and transport accident rates were comparable in the year before and after melatonin‐treatment initiation, the risk of self‐harm was highest in the months immediately prior to medication, and decreased thereafter. This was particularly prominent among adolescents with depression and/or anxiety, with females displaying greater absolute risks than males. Compared to the last unmedicated month, the 12 months post medication initiation had decreased relative risks for self‐harm, with an IRR [95% CI] in the month following melatonin‐treatment initiation of 0.46 [0.27–0.76] among adolescent females with psychiatric disorders, after excluding antidepressant users.ConclusionsDecreased risk of intentional self‐harm was observed following melatonin‐treatment initiation among females with depression and anxiety, suggesting that sleep interventions could be considered in an effort to reduce risk of self‐harm in this population.